Mutation Analysis in Cancer
作者： Keyur Pravinchandra Patel , John Galbincea , Rajyalakshmi Luthra
DOI: 10.1007/978-1-4614-2170-2_18
关键词:
摘要: Testing for the presence of genetic mutations yields useful diagnostic, therapeutic, and prognostic information has become standard care a variety hematologic solid tumors. The majority molecular tests use polymerase chain reaction–based approach. choice test methodology depends on many factors, such as type frequency mutation, anticipated volume, tumor type, sample cost technology, preexisting instruments.
springer.com
sci-hub.st 参考文章(17)
Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid Leukemia: An Algorithmic Approach Using High-Resolution Melting Curve Analysis The Journal of Molecular Diagnostics. ,vol. 13, pp. 678- 686 ,(2011) , 10.1016/J.JMOLDX.2011.06.004
Harvey F. Lodish, Molecular Cell Biology ,(1986)
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Keyur P. Patel, Farhad Ravandi, Deqin Ma, Abhaya Paladugu, Bedia A. Barkoh, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features. American Journal of Clinical Pathology. ,vol. 135, pp. 35- 45 ,(2011) , 10.1309/AJCPD7NR2RMNQDVF
Zhuang Zuo, Su S Chen, Pranil K Chandra, John M Galbincea, Matthew Soape, Steven Doan, Bedia A Barkoh, Hartmut Koeppen, L Jeffrey Medeiros, Rajyalakshmi Luthra, Application of COLD-PCR for improved detection of KRAS mutations in clinical samples Modern Pathology. ,vol. 22, pp. 1023- 1031 ,(2009) , 10.1038/MODPATHOL.2009.59
Adi F. Gazdar, Hisayuki Shigematsu, Joachim Herz, John D. Minna, Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers? Trends in Molecular Medicine. ,vol. 10, pp. 481- 486 ,(2004) , 10.1016/J.MOLMED.2004.08.008
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Stefano Giulieri, Oriol Manuel, QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity Expert Review of Molecular Diagnostics. ,vol. 11, pp. 17- 25 ,(2011) , 10.1586/ERM.10.109
Laia Agell, Silvia Hernández, Silvia de Muga, José A Lorente, Núria Juanpere, Raquel Esgueva, Sergi Serrano, Antoni Gelabert, Josep Lloreta, KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations. Modern Pathology. ,vol. 21, pp. 1470- 1478 ,(2008) , 10.1038/MODPATHOL.2008.145
Pei Lin, Dan Jones, L. Jeffrey Medeiros, Weina Chen, Francisco Vega-Vazquez, Rajyalakshmi Luthra, ActivatingFLT3Mutations Are Detectable in Chronic and Blast Phases of Chronic Myeloproliferative Disorders Other Than Chronic Myeloid Leukemia American Journal of Clinical Pathology. ,vol. 126, pp. 530- 533 ,(2006) , 10.1309/JT5BE2L1FGG8P8Y6